Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Serum prealbumin as prognostic indicator in Idiopathic pulmonary fibrosis. A glimmer of hope.

Aggarwal D.

Clin Respir J. 2019 Aug 2. doi: 10.1111/crj.13072. [Epub ahead of print]

PMID:
31374160
2.

In search for a predictive marker of acute exacerbations of idiopathic pulmonary fibrosis.

Moodley Y.

Respirology. 2019 Aug 1. doi: 10.1111/resp.13666. [Epub ahead of print] No abstract available.

3.
4.

Comparison of lymphocyte immune phenotypes in bronchoalveolar lavage of non-smoking patients with sarcoidosis and other interstitial lung diseases.

Novosadova E, Navratilova Z, Ordeltova M, Zurkova M, Zatloukal J, Kolek V, Petrek M.

J Thorac Dis. 2019 Jun;11(6):2287-2296. doi: 10.21037/jtd.2019.06.05.

5.

Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis.

Sakayori M, Terada J, Abe M, Hirasawa Y, Suzuki K, Yoshioka K, Tsushima K, Tatsumi K.

Drug Des Devel Ther. 2019 Jul 11;13:2295-2303. doi: 10.2147/DDDT.S208733. eCollection 2019.

6.

Circulating Adhesion Molecules and Subclinical Interstitial Lung Disease: The Multi-Ethnic Study of Atherosclerosis.

McGroder CF, Aaron CP, Bielinski SJ, Kawut SM, Tracy RP, Raghu G, Barr RG, Lederer DJ, Podolanczuk AJ.

Eur Respir J. 2019 Aug 1. pii: 1900295. doi: 10.1183/13993003.00295-2019. [Epub ahead of print]

PMID:
31371443
7.

The Anti-Fibrotic Effects of CG-745, an HDAC Inhibitor, in Bleomycin and PHMG-Induced Mouse Models.

Kim YS, Cha H, Kim HJ, Cho JM, Kim HR.

Molecules. 2019 Jul 31;24(15). pii: E2792. doi: 10.3390/molecules24152792.

Supplemental Content

Loading ...
Support Center